Camad, Afrah M.
HRN: 24-57-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
AMPICILLIN 250MG (VIAL)
12/17/2025
12/23/2025
IVT
250mg
Q6
Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes